List of insiders holdings for Inozyme Pharma Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Longitude Capital Partners III LLC Longitude Venture Partners III L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner | 2023-08-11 16:08:56 | 5,841,045 0 | 5,841,045 | Form 13D |
| Pivotal bioVenture Partners Fund I L.P. Pivotal bioVenture Partners Fund I G.P. L.P. Pivotal bioVenture Partners Fund I U.G.P. Ltd Director | 2024-02-12 21:06:26 | 4,494,851 0 | 4,494,851 | Form 13D |
| Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. HEALY JAMES Katabi Maha POWELL MICHAEL 10% Owner | 2024-02-20 19:11:01 | 4,280,308 0 | 4,280,308 | Form 13D |
| Rock Springs Capital Management LP Rock Springs Capital Master Fund LP Rock Springs Capital LLC 10% Owner | 2024-02-14 14:10:03 | 3,681,174 0 | 3,681,174 | Form 13G |
| MAKOWER JOSHUA 10% Owner | 2020-07-28 18:29:09 | 0 2,437,689 | 2,437,689 | Form 4 |
| Sonsini Peter W. 10% Owner | 2020-07-28 18:30:55 | 0 2,437,689 | 2,437,689 | Form 4 |
| SANDELL SCOTT D 10% Owner | 2020-07-28 18:29:54 | 0 2,437,689 | 2,437,689 | Form 4 |
| Makhzoumi Mohamad 10% Owner | 2020-07-28 18:28:20 | 0 2,437,689 | 2,437,689 | Form 4 |
| Florence Anthony A. Jr. 10% Owner | 2020-07-28 18:27:42 | 0 2,437,689 | 2,437,689 | Form 4 |
| BASKETT FOREST 10% Owner | 2020-07-28 18:26:52 | 0 2,437,689 | 2,437,689 | Form 4 |
| Hopfner Robert Lorne Director | 2023-08-03 20:01:15 | 0 1,571,741 | 1,571,741 | Form 4 |
| Novo Holdings A/S 10% Owner | 2021-07-30 16:31:00 | 1,167,706 0 | 1,167,706 | Form 13D |
| ALEXION PHARMACEUTICALS INC. 10% Owner | 2020-07-28 18:11:09 | 1,109,910 0 | 1,109,910 | Form 4 |
| Sanofi 10% Owner | 2020-07-29 06:06:37 | 0 520,125 | 520,125 | Form 4 |
| Braddock Demetrios 10% Owner | 2020-07-23 21:19:08 | 404,142 0 | 404,142 | Form 3 |
| Schlessinger Joseph 10% Owner | 2020-07-28 18:13:16 | 286,479 0 | 286,479 | Form 4 |
| Subramanian Sanjay SVP, CFO | 2024-03-15 08:30:05 | 165,000 0 | 165,000 | Form 4 |
| Bjarke Henric Bjorn SVP, COO | 2022-12-19 08:30:09 | 105,441 0 | 105,441 | Form 4 |
| Wenkert Deborah SVP, CMO | 2021-02-04 17:11:58 | 100,000 0 | 100,000 | Form 4 |
| Treco Douglas A CEO | 2024-04-03 17:23:07 | 95,665 0 | 95,665 | Form 4 |
| Jungles Steven J SVP, CTO | 2021-03-17 17:57:38 | 42,000 0 | 42,000 | Form 4 |
| Huertas Pedro SVP, CMO | 2021-01-14 16:17:14 | 36,074 0 | 36,074 | Form 4 |
| Bhagat Sarah M Director | 2023-06-15 16:05:07 | 16,000 0 | 16,000 | Form 4 |
| Edwards Martin Director | 2023-06-15 16:05:16 | 16,000 0 | 16,000 | Form 4 |
| DIAZ REINALDO M Director | 2023-06-15 16:05:20 | 16,000 0 | 16,000 | Form 4 |
| Bolte Axel Director | 2023-06-15 16:05:16 | 16,000 0 | 16,000 | Form 4 |
| Sullivan Lynne Marie Director | 2023-06-15 16:05:32 | 16,000 0 | 16,000 | Form 4 |
| Mathers Edward T Director | 2023-06-15 16:16:14 | 16,000 0 | 16,000 | Form 4 |
| DiPalma Stephen J. Interim CFO | 2021-05-18 16:18:59 | 15,000 0 | 15,000 | Form 4 |
| Basso Stephen SVP Finance (PFO) | 2021-03-25 16:05:22 | 13,000 0 | 13,000 | Form 4 |
| Inozyme Pharma Inc. Director | 2021-06-24 16:10:00 | 9367 0 | 9367 | Form 4 |
| Winton Matthew COO | 2024-04-03 17:23:00 | 3188 0 | 3188 | Form 4 |
| New Enterprise Associates 15 L.P. NEA Partners 15 L.P. NEA 15 GP LLC 10% Owner | 2024-02-14 18:08:47 | 0 0 | 0 | Form 13G |
| RA CAPITAL MANAGEMENT L.P. Kolchinsky Peter Shah Rajeev M. 10% Owner | 2021-11-15 16:35:14 | 0 0 | 0 | Form 13G |